MedTrace Logo

Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

NCT07338175 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1192

Last updated 2026-04-23

No results posted yet for this study

Summary

This is a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. It aims to evaluate the efficacy and safety of oral minocycline in patients with acute spontaneous intracerebral hemorrhage within 48 hours of onset.

Conditions

  • Intracerebral Hemorrhage

Interventions

DRUG

Minocycline hydrochloride capsules

50 mg per capsule, containing 50mg of Minocycline Hydrochloride

DRUG

Placebo capsules of Minocycline hydrochloride capsules

50 mg per capsule, containing 0 mg of Minocycline Hydrochloride

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-02
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07338175 on ClinicalTrials.gov